[Surgical treatment of adenocarcinoma in Barrett's esophagus and prognosis].
There is no consensus regarding the surgical approach to adenocarcinoma in Barrett's esophagus. From 1980 to 1988, 8 patients with adenocarcinoma in Barrett's esophagus were treated at the National Cancer Center Hospital. Seven patients underwent subtotal esophagectomy with extended lymph node dissection, and one transhiatal esophagogastrectomy with regional lymph node dissection. In 4 patients tumor invasion was limited within the submucosa and in 4 within the muscularis propria. Four of 8 patients had stage I disease. The 5-year survival rate for the 8 patients was 64.3%. Some reports have indicated that endoscopic survey for Barrett's esophagus is important for early diagnosis. We conclude that survival after esophagectomy for adenocarcinoma in Barrett's esophagus is dependent on the method of operation, and that patients with early lesions may expect significantly better survival after extended lymph node dissection.
Tsubosa
Y
Y
Department of Surgical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Watanabe
H
H
Katou
H
H
Tachimori
Y
Y
Igaki
H
H
Yamaguchi
H
H
Nakanishi
Y
Y
D000230:Adenocarcinoma / Q000601:surgery*; D000368:Aged; D001471:Barrett Esophagus / Q000150:complications* / Q000401:mortality; D004938:Esophageal Neoplasms / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016896:Treatment Outcome